UroGen Pharma Sponsored Study Titled 'Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC)' Posted To ClinicalTrials.gov; Study Is Recruiting